Seeking Alpha

Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

Announced Thorough Evaluation of a Range of Potential Strategic Opportunities Continued GBM Study Start-up Activities Ended Quarter with $25.9 million in Cash, Cash Equivalents and Marketable ...
Seeking Alpha

Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma

CHARLOTTESVILLE, Va., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (DFFN) today announced that its stockholders have voted to approve all proposals at a special meeting of ...
CNN

Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

Simultaneous patient enrollment planned in both the U.S. and Eastern Europe to speed time to data readout CHARLOTTESVILLE, Va., May 05, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: ...
Reuters

Diffusion Pharmaceuticals Files Prospectus Related To Offering Of Common Stock

Feb 6 (Reuters) - Diffusion Pharmaceuticals Inc: * DIFFUSION PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO OFFERING UP TO 12.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC ...
Reuters

Diffusion Pharmaceuticals Q3 loss per share $0.53

category Wall St falls as declines in Walmart, Palantir hit risk sentiment 5:17 PM UTC · Updated ago United Statescategory US labor market stable; hit from federal government belt tightening awaited 5 ...